The Therapeutic Goods Administration (TGA) recently announced that they have received Government approval to extend the transition period affecting most reclassified devices, as well as patient-matched devices, extending the deadline from 1 November 2024 to 1 July 2029.
Productlife Group Acquires Commercial Eyes, Expanding Its Footprint In The APAC Region
ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes, Australia’s leading pharmaceutical and medical device commercialisation company, specialising in regulatory affairs, pharmacovigilance, medical information, quality assurance,…
Season’s Greetings from Commercial Eyes!
We wish you and your loved ones a holiday filled with peace, joy, and cherished moments – and a New Year that brings health, happiness, and…
Understanding Risk Management Programs: Ensuring Patient Safety, Regulatory Compliance, and Optimized Therapy
Part 5 of 6: A poorly implemented Risk Management Program (RMP) can erode trust, increase risks, and jeopardise outcomes. Learn how thoughtful design and technology can enhance patient safety, regulatory…
Understanding the unique value proposition and buyer segmentation to develop investor ready research for a global hardware and SaMD company
Commercial Eyes’ client, Vitrafy has successfully completed their initial public offering (IPO) on the Australian Securities Exchange (ASX). We unpack the work Commercial Eyes delivered to inform and support the development…
At Commercial Eyes, we’re united in the fight against breast cancer—a cause close to our hearts
This year, our team came together for a special Breast Cancer Awareness Bake-off to honor survivors, foster community, and raise funds for research and patient care. With nearly 21,000 Australians…
ProductLife Group Highlights the Key Role of Artificial Intelligence (AI) in Transforming the Life Sciences Industry
Explore ProductLife Group’s latest insights on the transformative impact of AI in life sciences. From drug discovery to pharmacovigilance, learn how AI is shaping a smarter future for pharma. With…
Making the Right Call: Commercial Eyes’ Expertise in Assessing In-Licensing Opportunities
At Commercial Eyes, we empower our clients to make informed, confident decisions about whether to license a product by offering comprehensive, data-driven assessments that balance clinical promise with commercial viability….
Delivering Critical Therapies to Patients in Need through Managed Access Programs? Expert execution makes all the difference.
Outsourcing Managed Access Programs (MAPs) to specialised partners like Commercial Eyes offers pharmaceutical companies the significant advantage of freeing up internal staff time while ensuring ongoing compliance and…
Empowering Patients with Comprehensive Support: How Commercial Eyes’ Patient Support Programs Make a Difference
In part three of our six-part series, we focus on how the right design of Patient Support Programs (PSPs) empowers patients and improves outcomes in their treatment journey. At Commercial…
Unlocking Patient Access and HCP experience
In part two of our six-part series, we dive deeper into Access Programs, which, at their heart, play a pivotal role in bringing innovative treatments to patients prior to launch….
Enhancing Health Outcomes through Patient Programs
In this 6-part series, we explore how Commercial Eyes designs and delivers a range of different patient programs to address the multifaceted challenges that Healthcare Professionals and patients can encounter…
TRoVE database: a treasure chest of competitive insights
Powered by TRoVE: discover actionable insights from the latest Medicines Australia transparency…
Decoding Digital Footprints – Part Two
The Commercial Eyes’ Innovation Series features Q&A interviews with industry leaders to explore healthcare innovation in Australia. In “Decoding Digital Footprints (Part Two),” Salem Lassoued of Data Organica reveals how…
Decoding Digital Footprints – Part One
The Commercial Eyes’ Innovation Series features Q&A interviews with industry leaders, exploring healthcare innovation in Australia. In “Decoding Digital Footprints (Part One),” Salem Lassoued of Data Organica discusses how digital…
Digital Health Takes the Main Stage (and All the Other Stages)
The Digital Health Festival recently held in Melbourne highlighted the pervasive role of digital health within the healthcare system. This event attracted a massive audience, reflecting the sector’s growth and…
Bridging the Gap with Our Enhanced Patient Safety Services Offerings
Commercial Eyes offers tailored consultation, gap analysis, and business partner audit services to ensure clients are inspection-ready and compliant in…
Events & Webinars, Hot Topics, Latest News,
Unlocking the Potential of AI in Healthcare: Key Insights from the BioMelbourne Network Biosymposium
Can you anticipate your competitors’ plans & strategies? Can you predict their reactions to your competitive initiatives? Does your competitor have the capabilities to implement their strategy? Do you know…
World Health Day 2024 – Prioritising Health and Wellbeing
On World Health Day, the Commercial Eyes team reflects on the importance of accessing healthcare and how available and supportive wellbeing programs can positively impact our…
Events & Webinars, Hot Topics,
International Women’s Day 2024
Commercial Eyes was founded on the principles of inclusivity and flexibility, with a mission to empower the women in its workforce. On International Women’s Day, we proudly recognise the outstanding…
Integrated Expertise: Commercial Eyes’ Regulatory and Access Teams as Your Gateway to the Australasian Market
Navigating the complexities of market entry into Australia and New Zealand’s pharmaceutical, biotechnology, and MedTech sectors can be daunting; success hinges on navigating complex regulatory and market access pathways. It…
Competitive Intelligence in BANI world
Can you anticipate your competitors’ plans & strategies? Can you predict their reactions to your competitive initiatives? Does your competitor have the capabilities to implement their strategy? Do you know…